Skip to main content

Saturday, July 20:  All UR Medicine facilities are open as scheduled and providing safe patient care, with a goal to return all clinical services to full efficiency by early next week.
Patients: click here for more information. Faculty/Staff: click here for information.

menu
Flaum Eye Institute / Research / Labs / Wozniak Lab / Projects / Antimicrobial drug development

 

Antimicrobial drug development

Test tube image

Bacterial keratitis is an aggressive and devastating ocular disease that requires immediate, broad-spectrum antimicrobial treatment to mitigate tissue damage and maintain sight.  However, rising antibiotic resistance, particularly among Staphylococcus aureus isolates has rendered many current ophthalmic antibiotic ineffective.  Our lab is working to develop the next generation of ocular antibiotics to fill this critical need.  We are actively exploring novel, synergistic drug combinations as well identifying new antimicrobial classes using high-throughput screening methodologies.

« back to all projects